Yuan Ji

Active 1993–2026

Also published as
Yu'an Ji
369
Papers
28,184
Citations
85
h-index
288
i10-index

Citations

Citations per year for Yuan Ji1982: 1 citations1985: 1 citations1986: 1 citations1993: 2 citations1994: 34 citations1995: 92 citations1996: 138 citations1997: 166 citations1998: 114 citations1999: 90 citations2000: 70 citations2001: 41 citations2002: 37 citations2003: 25 citations2004: 21 citations2005: 41 citations2006: 49 citations2007: 40 citations2008: 60 citations2009: 70 citations2010: 94 citations2011: 95 citations2012: 97 citations2013: 123 citations2014: 127 citations2015: 111 citations2016: 175 citations2017: 227 citations2018: 265 citations2019: 741 citations2020: 1,010 citations2021: 1,115 citations2022: 1,036 citations2023: 922 citations2024: 1,811 citations2025: 993 citations2026: 64 citations1983–1984: no citations, so these years are not shown1987–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,575 citing papers, 25.1% of this breakdownUnited States: 3,195 citing papers, 22.5% of this breakdownUnited Kingdom: 710 citing papers, 5% of this breakdownGermany: 615 citing papers, 4.3% of this breakdownItaly: 514 citing papers, 3.6% of this breakdownCanada: 489 citing papers, 3.4% of this breakdownJapan: 389 citing papers, 2.7% of this breakdownFrance: 310 citing papers, 2.2% of this breakdownAustralia: 307 citing papers, 2.2% of this breakdownSpain: 298 citing papers, 2.1% of this breakdownNetherlands: 265 citing papers, 1.9% of this breakdownSouth Korea: 259 citing papers, 1.8% of this breakdown
0%25.1%Other 23.2%

Fields

  • Medicine41.8%
  • Biochemistry, Genetics and Molecular Biology35.1%
  • Pharmacology, Toxicology and Pharmaceutics3.8%
  • Computer Science3.8%
  • Engineering3.4%
  • Immunology and Microbiology3%
  • Other9.1%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis3.6%
  • Cancer Genomics and Diagnostics3.2%
  • Radiomics and Machine Learning in Medical Imaging2.4%
  • Cell death mechanisms and regulation2.4%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.2%
  • Cancer Immunotherapy and Biomarkers1.8%
  • Other84.4%

Coauthors

All papers

Open in search
  1. The evolutionary history of 2,658 cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David D.L. Bowtell, Hongtu Zhu, Gad Getz, Marcin Imieliński, Rameen Beroukhim, S. Cenk Şahinalp, Yuan Ji, Martin Peifer, Florian Markowetz, Ville Mustonen, Ke Yuan, Wenyi Wang, Quaid D. Morris, PCAWG Evolution & Heterogeneity Working Group, Stefan C. Dentro, Ignaty Leshchiner, Moritz Gerstung, Clemency Jolly, Kerstin Haase, Maxime Tarabichi, Jeff Wintersinger, Amit G. Deshwar, Kaixian Yu, Santiago Gonzalez, Yulia Rubanova, Geoff Macintyre, David J. Adams, Pavana Anur, Rameen Beroukhim, Paul C. Boutros, David D.L. Bowtell, Peter J. Campbell, Shaolong Cao, Elizabeth L. Christie, Marek Cmero, Yupeng Cun, Kevin J. Dawson, Jonas Demeulemeester, Nilgun Donmez, Ruben M. Drews, Roland Eils, Yu Fan, Matthew W. Fittall, Dale W. Garsed, Gad Getz, Gavin Ha, Marcin Imieliński, Lara Jerman, Yuan Ji, Kortine Kleinheinz, Juhee Lee, Henry Lee-Six, Dimitri Livitz, Salem Malikić, Florian Markowetz, Iñigo Martincorena, Thomas J. Mitchell, Ville Mustonen, Layla Oesper, Martin Peifer, Myron Peto, Benjamin J. Raphael, Daniel Rosebrock, S. Cenk Şahinalp, Adriana Salcedo, Matthias Schlesner, Steven E. Schumacher, Subhajit Sengupta, Ruian Shi, Seung Jun Shin and 1,341 more - Nature, Nat. 2020 cited by 1,141

  2. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baojin Hua, Xiaowu Huang, Weidong Jia, Yaming Li, Ye‐Xiong Li, Jun Liang, Tianshu Liu, Guoyue Lv, Yilei Mao, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Kaishan Tao, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhengyu Yin, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yongfu Zhao, Honggang Zheng, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jianqiang Cai, Weilin Wang, Xiujun Cai, Qiang Li, Feng Shen, Shukui Qin, Jiahong Dong, Jia Fan - Liver Cancer 2020 cited by 833

  3. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicholas McGranahan, Charles Swanton, Gad Getz, Paul C. Boutros, Marcin Imieliński, Rameen Beroukhim, S. Cenk Şahinalp, Yuan Ji, Martin Peifer, Iñigo Martincorena, Florian Markowetz, Ville Mustonen, Ke Yuan, Moritz Gerstung, Paul T. Spellman, Wenyi Wang, Quaid Morris, David C. Wedge, Peter Van Loo, Stefan C. Dentro, Ignaty Leshchiner, Moritz Gerstung, Clemency Jolly, Kerstin Haase, Maxime Tarabichi, Jeff Wintersinger, Amit G. Deshwar, Kaixian Yu, Santiago González, Yulia Rubanova, Geoff Macintyre, Jonas Demeulemeester, David J. Adams, Pavana Anur, Rameen Beroukhim, Paul C. Boutros, David D.L. Bowtell, Peter J. Campbell, Shaolong Cao, Elizabeth L. Christie, Marek Cmero, Yupeng Cun, Kevin J. Dawson, Nilgun Donmez, Ruben M. Drews, Roland Eils, Yu Fan, Matthew W. Fittall, Dale W. Garsed, Gad Getz, Gavin Ha, Marcin Imieliński, Lara Jerman, Yuan Ji, Kortine Kleinheinz, Juhee Lee, Henry Lee-Six, Dimitri Livitz, Salem Malikić, Florian Markowetz, Iñigo Martincorena, Thomas J. Mitchell, Ville Mustonen, Layla Oesper, Martin Peifer, Myron Peto, Benjamin J. Raphael, Daniel Rosebrock, S. Cenk Şahinalp, Adriana Salcedo and 19 more - Cell 2021 cited by 571

  4. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shuqun Cheng, Chaoliu Dai, Wenzhi Guo, Yabing Guo, Baojin Hua, Xiaowu Huang, Weidong Jia, Qiu Li, Tao Li, Xun Li, Yaming Li, Ye‐Xiong Li, Jun Liang, Changquan Ling, Tianshu Liu, Xiufeng Liu, Shichun Lu, Guoyue Lv, Yilei Mao, Zhiqiang Meng, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Ming Shi, Tianqiang Song, Kaishan Tao, Jianhua Wang, Kui Wang, Lu Wang, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Yang Jianyong, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhen‐Yu Yin, Yong Zeng, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yanqiao Zhang, Ming Zhao, Yongfu Zhao, Honggang Zheng, Ledu Zhou, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Lan Zhang, Chun Yang, Zhifeng Wu, Zhi Dai, Minshan Chen, Jianqiang Cai, Weilin Wang, Xiujun Cai, Q. Li, Feng Shen, Shukui Qin, Gao‐Jun Teng and 2 more - Liver Cancer 2023 cited by 452

  5. An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte–tumor cell crosstalk, local immunosuppression and tumor progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Haixiang Sun, Na Yao, Xiangyu Zhang, Shiyu Zhang, Xi Chen, Yang Yu, Yao Li, Fengming Liu, Zheng Wang, Shao‐Lai Zhou, Huanming Yang, Shuang Yang, Xun Xu, Longqi Liu, Qiang Gao, Zhao–You Tang, Xiangdong Wang, Jian Wang, Jia Fan, Shiping Liu, Xin‐Rong Yang, Ao Chen, Jian Zhou, Ao Chen, Jian Zhou - Cell Research 2023 cited by 218

  6. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 246

  7. Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yong Hou, Jia Fan, Xin‐Rong Yang - Nature Communications 2021 cited by 215

  8. Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jian Zhou, Xingxu Huang, David H. Peng, Liye Zhang, Jia Fan - Cancer Cell 2023 cited by 109

  9. Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

    Authors: , , , , , , , , , , , , , , - Liver Cancer 2021 cited by 237

  10. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

    Authors: , , , , , , , , , , , , , , , - Clinical Pharmacology & Therapeutics 2015 cited by 975

  11. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shichun Lu, Zheng Lu, Wei‐Fu Lv, Yilei Mao, Guoliang Shao, Ying‐Hong Shi, Tianqiang Song, Guang Tan, Yunqiang Tang, Kaishan Tao, Chidan Wan, Guangyi Wang, Lu Wang, Shunxiang Wang, Tianfu Wen, Baocai Xing, Bang‐De Xiang, Sheng Yan, Dinghua Yang, Guowen Yin, Tao Yin, Zhenyu Yin, Zhengping Yu, Bixiang Zhang, Jialin Zhang, Shuijun Zhang, Ti Zhang, Yamin Zhang, Yubao Zhang, Aibin Zhang, Haitao Zhao, Ledu Zhou, Wu Zhang, Zhenyu Zhu, Shukui Qin, Feng Shen, Xiujun Cai, Gao‐Jun Teng, Jianqiang Cai, Minshan Chen, Qiang Li, Lianxin Liu, Weilin Wang, Tingbo Liang, Jiahong Dong, Xiaoping Chen, Xuehao Wang, Shusen Zheng, Jia Fan - HepatoBiliary Surgery and Nutrition 2022 cited by 198

  12. Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 154

  13. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guoyue Lv, Yi-Lei Mao, Wei-Xin Ren, Hong-Cheng Shi, Wen-Tao Wang, Xiaoying Wang, Bao-Cai Xing, Jian-Ming Xu, Jian-Yong Yang, Ye-Fa Yang, Sheng-Long Ye, Zheng-Yu Yin, Bo-Heng Zhang, Shui-jun Zhang, Wei-Ping Zhou, Ji-Ye Zhu, Rong Liu, Ying-Hong Shi, Yong-Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jian-qiang Cai, Wei–Lin Wang, Jiahong Dong, Qiang Li, Feng Shen, Shu-Kui Qin, Jia Fan - Liver Cancer 2018 cited by 688

  14. Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Signal Transduction and Targeted Therapy 2023 cited by 148

  15. Distributed Finite-Time Safety Consensus Control of Vehicle Platoon With Senor and Actuator Failures

    Authors: , , , , , - IEEE Transactions on Vehicular Technology, IEEE Trans. Veh. Technol. 2022 cited by 62

  16. Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2019 cited by 161

  17. Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma

    Authors: , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2022 cited by 60

  18. Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2017 cited by 255

  19. A Pharmacogenomic Landscape in Human Liver Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Haibin Zhang, Yixue Li, Lijian Hui - Cancer Cell 2019 cited by 218

  20. Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , - Annals of Surgical Oncology 2022 cited by 72

  21. A 3D culture system improves the yield of MSCs-derived extracellular vesicles and enhances their therapeutic efficacy for heart repair

    Authors: , , , , , , , , , , , , , - Biomedicine & Pharmacotherapy 2023 cited by 52

  22. Recommendations for Clinical CYP2D6 Genotyping Allele Selection

    Authors: , , , , , , , , , , , , - Journal of Molecular Diagnostics 2021 cited by 154

  23. The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 84

  24. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme

    Authors: - Cell 1993 cited by 2,491